Wall Street Experts
ver. ZuMIgo(08/25)
Spero Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 90
EBIT TTM (mln): -1
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
| Rok finansowy |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
0 |
0 |
2 |
4 |
5 |
9 |
18 |
49 |
97 |
48 |
| Przychód Δ r/r |
0.0% |
inf% |
490.7% |
100.4% |
19.6% |
96.8% |
95.7% |
166.1% |
99.1% |
-50.4% |
| Marża brutto |
0.0% |
100.0% |
100.0% |
100.0% |
-1287.1% |
-618.1% |
93.9% |
96.8% |
99.6% |
100.0% |
| EBIT (mln) |
-13 |
-33 |
-42 |
-43 |
-63 |
-79 |
-88 |
-42 |
20 |
-73 |
| EBIT Δ r/r |
0.0% |
149.3% |
25.6% |
2.6% |
47.7% |
25.1% |
11.2% |
-52.0% |
-146.8% |
-471.6% |
| EBIT (%) |
0.0% |
-9916.7% |
-2108.6% |
-1079.3% |
-1333.1% |
-847.9% |
-481.9% |
-86.9% |
20.4% |
-152.9% |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
3 |
0 |
0 |
| EBITDA (mln) |
-13 |
-34 |
-42 |
-43 |
-63 |
-79 |
-87 |
-19 |
20 |
-72 |
| EBITDA(%) |
0.0% |
-10006.6% |
-2108.6% |
-1079.3% |
-1333.1% |
-847.9% |
-478.6% |
-39.0% |
20.8% |
-151.1% |
| Podatek (mln) |
-3 |
-8 |
-0 |
1 |
-1 |
-1 |
2 |
2 |
3 |
0 |
| Zysk Netto (mln) |
-10 |
-25 |
-46 |
-42 |
-60 |
-78 |
-91 |
-48 |
23 |
-69 |
| Zysk netto Δ r/r |
0.0% |
151.0% |
80.8% |
-9.6% |
44.4% |
28.8% |
17.8% |
-47.4% |
-147.5% |
-400.6% |
| Zysk netto (%) |
0.0% |
-7609.3% |
-2329.3% |
-1050.5% |
-1269.0% |
-830.9% |
-500.1% |
-98.9% |
23.6% |
-142.9% |
| EPS |
-1.54 |
-3.86 |
-17.82 |
-2.6 |
-3.31 |
-3.46 |
-2.96 |
-1.28 |
0.43 |
-1.27 |
| EPS (rozwodnione) |
-1.54 |
-3.86 |
-17.82 |
-2.6 |
-3.31 |
-3.46 |
-2.96 |
-1.28 |
0.43 |
-1.27 |
| Ilośc akcji (mln) |
7 |
7 |
3 |
16 |
18 |
22 |
31 |
38 |
53 |
54 |
| Ważona ilośc akcji (mln) |
7 |
7 |
3 |
16 |
18 |
22 |
31 |
38 |
53 |
54 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |